Forte Biosciences, Inc.
NASDAQ:FBRX
6.73 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 11.961 | 41.1 | 42.044 | 58.765 | 6.939 | 40.813 | 35.933 | 5.51 | 8.15 |
| Short Term Investments
| 25.164 | 0 | 0 | 0 | 12.835 | 55.273 | 52.792 | 25.735 | 50.76 |
| Cash and Short Term Investments
| 37.125 | 41.1 | 42.044 | 58.765 | 6.939 | 96.086 | 88.725 | 31.245 | 58.91 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 1.202 | 0.07 | 0.088 | 0.076 | 0.053 | 1.662 | 1.904 | 1.216 | 1.295 |
| Total Current Assets
| 38.327 | 41.511 | 42.52 | 59.898 | 7.506 | 97.748 | 90.629 | 32.461 | 60.205 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 0.109 | 0 | 0 | 0.097 | 0.151 | 3.973 | 1.217 | 0.743 | 0.445 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.544 | 0.486 | 0.786 | 1.244 | 0 | 1.36 | 0.227 | 2.147 | 1.525 |
| Total Non-Current Assets
| 0.653 | 0.486 | 0.786 | 1.341 | 0.151 | 5.333 | 1.444 | 2.89 | 1.97 |
| Total Assets
| 38.98 | 41.997 | 43.306 | 61.239 | 7.657 | 103.081 | 92.073 | 35.351 | 62.175 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 1.424 | 1.153 | 0.946 | 1.24 | 1.569 | 3.404 | 1.951 | 1.666 | 1.3 |
| Short Term Debt
| 0 | 0 | 0 | 0 | 4.744 | -0.036 | 7.2 | 7.2 | 0.6 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | -4.744 | 0.036 | 0.059 | 0.079 | 0.145 |
| Other Current Liabilities
| 2.242 | 2.026 | 0.812 | 1.019 | 0.343 | 13.13 | 8.12 | 5.437 | 3.89 |
| Total Current Liabilities
| 3.666 | 3.179 | 1.758 | 2.259 | 1.912 | 16.534 | 17.33 | 14.382 | 5.935 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 0 | 0 | 0 | 0 | 4.027 | 26.201 | 3.625 | 13.779 | 16.873 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0.036 | 0.068 | 0.108 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | -0.036 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 1.153 | 0 | 0 | 6.488 | 2.201 | 0.036 | 0.126 | 0.176 |
| Total Non-Current Liabilities
| 0 | 1.153 | 0 | 0 | 10.515 | 28.402 | 3.661 | 13.973 | 17.157 |
| Total Liabilities
| 3.666 | 3.179 | 1.758 | 2.259 | 12.427 | 44.936 | 20.991 | 28.355 | 23.092 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 43.306 | 61.239 | 10.515 | 5.659 | 92.073 | 131.413 | 131.413 |
| Common Stock
| 0.036 | 0.021 | 0.015 | 0.013 | 0.001 | 0.023 | 0.02 | 0.002 | 0.002 |
| Retained Earnings
| -118.52 | -87.044 | -73.165 | -51.457 | -4.97 | -215.884 | -166.929 | -128 | -94.512 |
| Accumulated Other Comprehensive Income/Loss
| 0.004 | 0 | -43.306 | -61.239 | 0.01 | -0.023 | -0.034 | -2.414 | -0.058 |
| Other Total Stockholders Equity
| 153.794 | 125.841 | 114.698 | 110.424 | -10.325 | 268.37 | 145.952 | 5.995 | 2.238 |
| Total Shareholders Equity
| 35.314 | 38.818 | 41.548 | 58.98 | -4.77 | 58.145 | 71.082 | 6.996 | 39.083 |
| Total Equity
| 35.314 | 38.818 | 41.548 | 58.98 | -4.77 | 58.145 | 71.082 | 6.996 | 39.083 |
| Total Liabilities & Shareholders Equity
| 38.98 | 41.997 | 43.306 | 61.239 | 7.657 | 103.081 | 92.073 | 35.351 | 62.175 |